RecruitingPhase 1NCT06351904

A Study of RAG-01 in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Who Have Failed Bacillus Calmette Guérin (BCG) Therapy

Studying Muscular tumor

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Ractigen Therapeutics.
Principal Investigator
Laurence Krieger, MBCHB
GenesisCare, 7 Westbourne Street, St Leonards, NSW 2065, Australia
Intervention
RAG-01(drug)
Enrollment
72 enrolled
Eligibility
18-75 years · All sexes
Timeline
20242028

Study locations (3)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06351904 on ClinicalTrials.gov

Other trials for Muscular tumor

Additional recruiting or active studies for the same condition.

See all trials for Muscular tumor

← Back to all trials